Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor
Clinical trial NCT04966481 · RECRUITING
Trial details
- NCT number
- NCT04966481
- Sponsor
- Washington University School of Medicine
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-06
- Primary completion
- 2028-02-28
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.